19–24 May 2024
Music City Center
US/Central timezone

Status of helium ion beams commissioning at MedAustron ion therapy center

TUPS06
21 May 2024, 16:00
2h
Blues (MCC Exhibit Hall A)

Blues

MCC Exhibit Hall A

Poster Presentation MC4.A04 Circular Accelerators Tuesday Poster Session

Speaker

Greta Guidoboni (EBG MedAustron GmbH)

Description

MedAustron is a synchrotron-based cancer therapy center located in Lower Austria. Patients are treated with proton and carbon ion beams in an energy range of 62-252 MeV/u and of 120-400 MeV/u respectively. The facility features three clinical irradiation rooms, among which horizontal and vertical beam lines as well as a proton gantry are available for treatment. A fourth irradiation room (IR1) is dedicated to non-clinical research activities among which helium ion beams are currently under commissioning. Helium ions are also promising future candidates for clinical treatment due their favorable physical and biological properties. At MedAustron the beam commissioning up to IR1 is near completion. A large energy range (i.e. 39-402 MeV/u) has been commissioned with the support of Monte Carlo simulations performed by the future users. The beam properties in terms of spot size and beam roundness obtained at the isocenter fulfill the user requirements. In this work we present the helium commissioning status with the main focus on the recent results obtained from the commissioning of the synchrotron and transfer line up to the isocenter in IR1.

Region represented Europe
Paper preparation format Word

Primary author

Nadia Gambino (EBG MedAustron GmbH)

Co-authors

Greta Guidoboni (EBG MedAustron GmbH) Matthias Kausel (EBG MedAustron GmbH) Mauro Pivi (EBG MedAustron GmbH) Fabien Plassard (EBG MedAustron GmbH) Valeria Rizzoglio (EBG MedAustron GmbH) Ivan Strasik (GSI Helmholtzzentrum für Schwerionenforschung GmbH) Lorenz Fischl (EBG MedAustron GmbH) Liviu Penescu (Abstract Landscapes) Dale Prokopovich (EBG MedAustron GmbH)

Presentation materials

There are no materials yet.